Cat: PA1000-8069

Recombinant Human NID2 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    NID2

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    NID2;Nidogen-2

  • Species

    Human

  • Source

    E. coli

  • Tag

    His tag N-Terminus

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q14112

  • Expression Region

    1-969aa

  • AA Sequence

    MEGDRVAGRPVLSSLPVLLLLQLLMLRAAALHPDELFPHGESWGDQLLQE GDDESSAVVKLANPLHFYEARFSNLYVGTNGIISTQDFPRETQYVDYDFP TDFPAIAPFLADIDTSHGRGRVLYRVNGKVSGHLHVGHTPVHFTDVDLHA YIVGNDGRAYTAISHIPQPAAQALLPLTPIGGLFGWLFALEKPGSENGFS LAGAAFTHDMEVTFYPGEETVRITQTAEGLDPENYLSIKTNIQGQVPYVP ANFTAHISPYKELYHYSDSTVTSTSSRDYSLTFGAINQTWSYRIHQNITY QVCRHAPRHPSFPTTQQLNVDRVFALYNDEERVLRFAVTNQIGPVKEDSD PTPVNPCYDGSHMCDTTARCHPGTGVDYTCECASGYQGDGRNCVDENECA TGFHRCGPNSVCINLPGSYRCECRSAYEFADDRHTCILITPPANPCEDGS HTCAPAGQARCVHHGGSTFSCACLPGYAGDGHQCTDVDECSENRCHPAAT CYNTPGSFSCRCQPGYYGDGFQCIPDSTSSLTPCEQQQRHAQAQYAYPGA RFHIPQCDEQGNFLPLQCHGSTGFCWCVDPDGHEVPGTQTPPGSTPPHCG PSPEPTQRPPTICERWRENLLEHYGGTPRDDQYVPQCDDLGHFIPLQCHG KSDFCWCVDKDGREVQGTRSQPGTTPACIPTVAPPMVRPTPRPDVTPPSV GTFLLYTQGQQIGYLPLNGTRLQKDAAKTLLSLHGSIIVGIDYDCRERMV YWTDVAGRTISRAGLELGAEPETIVNSGLISPEGLAIDHIRRTMYWTDSV LDKIESALLDGSERKVLFYTDLVNPRAIAVDPIRGNLYWTDWNREAPKIE TSSLDGENRRILINTDIGLPNGLTFDPFSKLLCWADAGTKKLECTLPDGT GRRVIQNNLKYPFSIVSYADHFYHTDWRRDGVVSVNKHSGQFTDEYLPEQ RSHLYGITAVYPYCPTGRK

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

NID2, or Nidogen-2, is an extracellular matrix (ECM) protein that plays a critical role in tissue architecture and cell-matrix interactions. It is primarily involved in the assembly and stabilization of basement membranes, a specialized type of ECM that underpins various cellular layers in tissues. Research into NID2 has gained significance due to its implications in various physiological processes and pathologies, including cancer metastasis, tissue repair, and fibrosis. Studies show that NID2 interacts with other key ECM components, such as laminins and collagen, influencing cellular behaviors such as adhesion, migration, and differentiation. Moreover, altered levels of NID2 expression have been linked to several diseases, highlighting its potential as a biomarker and therapeutic target. Recent advances in recombinant protein technology have facilitated the study of NID2 by enabling the production of functional recombinant NID2 protein. These studies aim to elucidate its structural properties, molecular interactions, and biological functions in a controlled environment. Understanding the role of NID2 could provide insights into its therapeutic potential in diseases characterized by ECM remodeling, offering new avenues for intervention and treatment strategies. Overall, the research on NID2 recombinant proteins is a promising field that bridges basic biology and clinical applications, seeking to unravel the complexities of ECM dynamics in health and disease.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US